Skip to main content
Catalent Pharma Solutions, Inc. (CTLT)
Dec 18, 2024 - CTLT was delisted (reason: acquired by Novo Holdings)
63.48
0.00 (0.00%)
Inactive · Last trade price on Dec 17, 2024

Catalent Revenue

Catalent had revenue of $453.10M in the quarter ending March 31, 2014, with 1.36% growth. This brings the company's revenue in the last twelve months to $1.81B, up 2.25% year-over-year. In the fiscal year ending June 30, 2013, Catalent had annual revenue of $1.80B with 6.22% growth.

Revenue (ttm)
$1.81B
Revenue Growth
+2.25%
P/S Ratio
n/a
Revenue / Employee
$218,470
Employees
17,800
Market Cap
n/a

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20131.80B105.50M6.22%
Jun 30, 20121.69B163.00M10.64%
Jun 30, 20111.53B51.40M3.47%
Jun 30, 20101.48B-81.20M-5.20%
Jun 30, 20091.56B-256.10M-14.09%
Jun 30, 2008 Pro Pro Pro
Jun 30, 2007 Pro Pro Pro
Jun 30, 2006 Pro Pro Pro
Jun 30, 2005 Pro Pro Pro
Mar 31, 1998 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CTLT News

More News